From: Value of next-generation sequencing in inherited arrhythmia syndromes
Ā | NGS (nā=ā17) | Sanger (nā=ā19) | Total (nā=ā36) |
---|---|---|---|
Ā Gene sequencing method | |||
Age | 42.6āĀ±ā3.6 | 47.2āĀ±ā2.1 | 45.1āĀ±ā2.1 |
Sex (male) | 16 (94.1%) | 18 (94.7%) | 34 (94.4%) |
Ā Gene sequencing indication | |||
Proband | 11 (64.7%) | 18 (94.7%) | 29 (80.6%) |
Family member | 6 (35.3%) | 1 (5.2%) | 7 (19.4%) |
Ā Past history | |||
HTN | 2 (11.8%) | 2 (10.5%) | 4 (11.1%) |
DM | 0 (0.0%) | 1 (5.2%) | 1 (2.8%) |
CVA | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
MI | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Smoking | 3 (17.6%) | 7 (36.8%) | 10 (27.8%) |
FHx of SCD | 3 (17.6%) | 3 (15.8%) | 6 (16.7%) |